Woodline Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.4M | Sell |
|
|||||
|
2025
Q2 | $52.7M | Buy |
|
|||||
|
2025
Q1 | $47.5M | Sell |
|
|||||
|
2024
Q4 | $43.7M | Buy |
|
|||||
|
2024
Q3 | $35.1M | Buy |
|
|||||
|
2024
Q2 | $27.1M | Buy |
|
|||||
|
2024
Q1 | $29.6M | Buy |
|
|||||
|
2023
Q4 | $2.03M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $32.7M | Buy |
|
|||||
|
2022
Q4 | $11.6M | Sell |
|
|||||
|
2022
Q3 | $21.8M | Buy |
|
|||||
|
2022
Q2 | $9.87M | Sell |
|
|||||
|
2022
Q1 | $13.1M | Sell |
|
|||||
|
2021
Q4 | $30.2M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $7.69M | Buy |
|